Tevogen Bio will host an AI panel at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 13, 2025. The discussion, titled "AI in Biopharma: Next Frontier of Medical Innovation," will feature Dr. David Rhew from Microsoft and Mittul Mehta from Tevogen.AI, along with Dr. Sean Tunis from Rubix Health. They will explore the potential of AI to revolutionize drug discovery, accelerate development timelines, enhance patient accessibility, foster innovation, and reduce costs. The panel will highlight how Tevogen's AI capabilities are being used to advance precision T cell therapies for various diseases.
https://www.manilatimes.net/2024/12/23/tmt-newswire/globenewswire/tevogen-bio-to-host-panel-ai-in-biopharma-next-frontier-of-medical-innovation-during-the-43rd-annual-jp-morgan-healthcare-conference/2026860